| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 1.000 | None | 0.985 | 1097 | 32 | 1992 | 2020 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.800 | strong | 0.985 | 453 | 8 | 1991 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.991 | 425 | 0 | 1993 | 2020 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.983 | 405 | 5 | 1996 | 2020 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.400 | None | 0.986 | 289 | 4 | 1993 | 2020 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 0.963 | 246 | 0 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 231 | 34 | 1986 | 2020 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 197 | 16 | 1992 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.973 | 182 | 3 | 1989 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.700 | None | 0.969 | 159 | 5 | 2009 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 156 | 9 | 1989 | 2019 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.400 | strong | 0.958 | 144 | 0 | 1982 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.400 | None | 0.986 | 142 | 0 | 1990 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.700 | None | 0.961 | 129 | 9 | 2010 | 2019 | ||||||||
|
CD33 molecule | 0.524 | 0.769 | 5.7E-07 |
|
disease | 0.400 | None | 0.958 | 120 | 1 | 1991 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.800 | limited | 0.955 | 112 | 5 | 2009 | 2019 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.400 | None | 0.970 | 101 | 0 | 1987 | 2020 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
disease | 0.500 | None | 0.960 | 101 | 7 | 1995 | 2020 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
disease | 0.400 | None | 0.960 | 99 | 0 | 1996 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.959 | 97 | 3 | 1994 | 2020 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.100 | None | 0.968 | 95 | 0 | 1989 | 2020 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
disease | 0.400 | None | 0.987 | 79 | 0 | 1996 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.987 | 78 | 6 | 1984 | 2019 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.500 | None | 0.987 | 75 | 6 | 1992 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.972 | 72 | 2 | 2000 | 2020 |